A legal fight over a single amino acid could set retatrutide's exclusivity window, its Medicare negotiation clock, and its competitive future.
Commentary|Podcasts|June 14, 2024
Frameworks for Advancing Health Equity: Immigrant Health
Author(s)Giuliana Grossi
Kheir Mugwaneza, the lead project manager of the Immigrant and Refugee Health Program at Allegheny Health Network, discusses how the program is working to address gaps in care for this community.
Advertisement
In this "Frameworks for Advancing Health Equity" episode, Kheir Mugwaneza, the lead project manager of the Immigrant and Refugee Health Program at
The Managed Care Cast series
Advertisement
Related to this article
Stutsky explains why shifting therapy perceptions had more pharmacist touchpoints and longer time on therapy among patients with ATTR-CM.
Medicaid expansion was associated with lower colorectal cancer mortality, with the largest reductions in Hispanic patients and stage IV disease.
Amanda Velazquez, MD, discusses GLP-1 formulary strategies, overcoming prior authorization hurdles, and building scalable obesity care infrastructure.
Cepheid's Connie Savor, MD, MBA, explains where its 13-pathogen respiratory panel fits in diagnostic stewardship and antibiotic decisions.
Even when physicians prescribe guideline-preferred therapies, step therapy and prior authorization can delay or restrict access to CLL therapies.
The study authors note there is an urgent need for "innovative value-based and alternative payment models of care."
A JAMA analysis of 2021-2023 death records found heat-related mortality varied sharply by occupation and industry among working-age US adults.
Advertisement
Advertisement
Trending on AJMC
1
MASH Fibrosis, Not Resolution, Predicts Mortality: Zobair Younossi, MD
2
FDA Approves Once-Monthly Subcutaneous Olanzapine for Schizophrenia
3
Multi-Hit TP53 Linked to Shorter Survival in Chronic-Phase MPN Cohorts
4
Navigating GLP-1 Access & Prior Authorizations: Amanda Velazquez, MD
5